BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30378279)

  • 1. Clinical characteristics and quality of life in Chinese patients with multiple system atrophy.
    Du JJ; Wang T; Huang P; Cui S; Gao C; Lin Y; Fu R; Zhou H; Chen S
    Brain Behav; 2018 Dec; 8(12):e01135. PubMed ID: 30378279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in multiple system atrophy.
    Schrag A; Geser F; Stampfer-Kountchev M; Seppi K; Sawires M; Köllensperger M; Scherfler C; Quinn N; Pellecchia MT; Barone P; Del Sorbo F; Albanese A; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Nilsson CF; Widner H; Lindvall O; Giladi N; Gurevich T; Daniels C; Deuschl G; Coelho M; Sampaio C; Abele M; Klockgether T; Schimke N; Eggert KM; Oertel W; Djaldetti R; Colosimo C; Meco G; Poewe W; Wenning GK;
    Mov Disord; 2006 Jun; 21(6):809-15. PubMed ID: 16502399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal lobe function, behavioral changes and quality of life in patients with multiple system atrophy.
    Zhang L; Cao B; Zou Y; Wei QQ; Ou R; Zhao B; Yang J; Wu Y; Shang H
    Restor Neurol Neurosci; 2019; 37(1):11-19. PubMed ID: 30741706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].
    Yan XM; Li PJ; Li W; Wang XM; Yu S
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2933-2939. PubMed ID: 37752052
    [No Abstract]   [Full Text] [Related]  

  • 5. Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy.
    Fetoni V; Soliveri P; Monza D; Testa D; Girotti F
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):541-4. PubMed ID: 10201434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freezing of gait in Chinese patients with multiple system atrophy: prevalence and risk factors.
    Chen Y; Wang H; Huang H; Chen Y; Xu Y
    Front Neurosci; 2023; 17():1194904. PubMed ID: 37351425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson's disease and multiple system atrophy--comparison with normal elderly.
    Wang Y; Shao WB; Gao L; Lu J; Gu H; Sun LH; Tan Y; Zhang YD
    PLoS One; 2014; 9(12):e116123. PubMed ID: 25546308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy.
    Barcelos LB; Saad F; Giacominelli C; Saba RA; de Carvalho Aguiar PM; Silva SMA; Borges V; Bertolucci PHF; Ferraz HB
    Clin Neurol Neurosurg; 2018 Jan; 164():121-126. PubMed ID: 29223069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of quality of life in multiple system atrophy and Parkinson's disease].
    Torny F; Lacoste M; Videaud H; Chouly M; Parveau MC; Couratier P
    Rev Neurol (Paris); 2009 Nov; 165(11):911-5. PubMed ID: 19324385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sleep-related breathing disorder on motor and non-motor symptoms in multiple system atrophy.
    Cao B; Wei QQ; Ou R; Zhao B; Hu T; Chen Y; Yang J; Lei F; Tang X; Shang HF
    Sleep Breath; 2018 Dec; 22(4):981-987. PubMed ID: 29380098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.
    Winter Y; Spottke AE; Stamelou M; Cabanel N; Eggert K; Höglinger GU; Sixel-Doering F; Herting B; Klockgether T; Reichmann H; Oertel WH; Dodel R
    Neurodegener Dis; 2011; 8(6):438-46. PubMed ID: 21576919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.
    Kawai Y; Suenaga M; Takeda A; Ito M; Watanabe H; Tanaka F; Kato K; Fukatsu H; Naganawa S; Kato T; Ito K; Sobue G
    Neurology; 2008 Apr; 70(16 Pt 2):1390-6. PubMed ID: 18413566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study.
    Jecmenica-Lukic MV; Pekmezovic TD; Petrovic IN; Dragasevic NT; Kostić VS
    Acta Neurol Belg; 2018 Dec; 118(4):589-595. PubMed ID: 29949032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
    Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Østergaard K; Dupont E; Schimke N; Eggert KM; Oertel W; Djaldetti R; Poewe W;
    Mov Disord; 2006 Feb; 21(2):179-86. PubMed ID: 16161136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in patients with multiple system atrophy using the EQ-5D-5L.
    Xiao Y; Zhang L; Wei Q; Ou R; Hou Y; Liu K; Lin J; Yang T; Shang H
    Brain Behav; 2022 Oct; 12(10):e2774. PubMed ID: 36124355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-related symptoms in multiple system atrophy: determinants and impact on disease severity.
    Lin JY; Zhang LY; Cao B; Wei QQ; Ou RW; Hou YB; Liu KC; Xu XR; Jiang Z; Gu XJ; Liu J; Shang HF
    Chin Med J (Engl); 2020 Nov; 134(6):690-698. PubMed ID: 33234871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of multiple system atrophy: a prospective European cohort study.
    Wenning GK; Geser F; Krismer F; Seppi K; Duerr S; Boesch S; Köllensperger M; Goebel G; Pfeiffer KP; Barone P; Pellecchia MT; Quinn NP; Koukouni V; Fowler CJ; Schrag A; Mathias CJ; Giladi N; Gurevich T; Dupont E; Ostergaard K; Nilsson CF; Widner H; Oertel W; Eggert KM; Albanese A; del Sorbo F; Tolosa E; Cardozo A; Deuschl G; Hellriegel H; Klockgether T; Dodel R; Sampaio C; Coelho M; Djaldetti R; Melamed E; Gasser T; Kamm C; Meco G; Colosimo C; Rascol O; Meissner WG; Tison F; Poewe W;
    Lancet Neurol; 2013 Mar; 12(3):264-74. PubMed ID: 23391524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.